GlassScriptPhysician profile
Douglas R Brown
NPI 1902883507
$2,456.38
in general payments reported to CMS, 2019-2025
38 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $237 · 2021: $348 · 2022: $436 · 2023: $359 · 2024: $306 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $362.04 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $258.84 | 2019-2025 | Mounjaro, Jardiance |
| Astellas Pharma US INC | $252.15 | 2020-2025 | Veozah |
| Novo Nordisk INC | $167.92 | 2019-2025 | Rybelsus, Ozempic |
| Amgen INC. | $119.31 | 2019-2025 | Evenity, Prolia |
| Otsuka America Pharmaceutical, INC. | $117.07 | 2022-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $108.62 | 2019-2025 | Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $101.21 | 2019-2025 | Trelegy Ellipta |
| Allergan, INC. | $77.50 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.63 | 2019-2025 | Xifaxan |
| Pfizer INC. | $65.66 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $60.69 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.79 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.56 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $46.83 | 2020-2024 | Capvaxive |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.